Journal Mobile Options
Table of Contents
Vol. 35, No. 2-3, 2002
Issue release date: March–June 2002
Section title: Topical Review of Experience with Current Diagnostic Systems
Psychopathology 2002;35:82–88
(DOI:10.1159/000065124)

Experience with ICD-10/DSM-IV Substance Use Disorders

Rounsaville B.J.
Yale University School of Medicine, VA CT Healthcare Systems, West Haven, Conn., USA

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Topical Review of Experience with Current Diagnostic Systems

Published online: 7/17/2002
Issue release date: March–June 2002

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 2

ISSN: 0254-4962 (Print)
eISSN: 1423-033X (Online)

For additional information: http://www.karger.com/PSP

Abstract

‘Substance Use Disorders’ represents a diagnostic subgroup in which ICD-10 and DSM-IV agree in most generalities and many particulars. Both systems’ use disorders are based on the ‘dependence syndrome’ construct by Edwards and Gross and include a large and overlapping set of substance-induced syndromes. Differences at the category level are limited to DSM-IV ‘abuse’ vs. ICD-10 ‘harmful use’, elimination of ‘pathological alcohol intoxication’ from DSM-IV and inclusion of substance-induced ‘sexual dysfunctions and sleep disorders’ in DSM-IV, but not in ICD-10. Cross-system reconciliation would entail few conceptual compromises but many criterion changes. Before embarking on a reconciliation process, the benefits of a common, world-wide nomenclature must be weighed against the many costs of changing either system. Even small changes can yield large differences in rates, reduce comparability across data gathered with different systems and incur considerable costs related to clinician retraining, changes in record keeping and changes in diagnostic interview schedules. Moreover, empirical data can have limited impact on the choices between the two systems because findings are either absent or equivocal, particularly for differences at the criterion level. Nevertheless, more research is needed particularly to examine the comparative reliability and validity of abuse and harmful use diagnoses.

© 2002 S. Karger AG, Basel


  

Article Information

Number of Print Pages : 7
Number of Figures : 0, Number of Tables : 2, Number of References : 37

  

Publication Details

Psychopathology (International Journal of Descriptive Psychopathology Phenomenology and Clinical Diagnositcs)
Founded 1897 as ‘Monatsschrift für Psychiatrie und Neurologie’

Vol. 35, No. 2-3, Year 2002 (Cover Date: March-June 2002)

Journal Editor: E. Gabriel, Vienna; C. Mundt, Heidelberg
ISSN: 0254–4962 (print), 1423–033X (Online)

For additional information: http://www.karger.com/journals/psp


Article / Publication Details

First-Page Preview
Abstract of Topical Review of Experience with Current Diagnostic Systems

Published online: 7/17/2002
Issue release date: March–June 2002

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 2

ISSN: 0254-4962 (Print)
eISSN: 1423-033X (Online)

For additional information: http://www.karger.com/PSP


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.